Cyr61 promotes breast tumorigenesis and cancer progression

Oncogene

Volumn 21, Issue 53, 2002, Pages 8178-8185

  Tsai, Miaw Sheue ^a   Bogart, Daphne F ^a,b   Castañeda, Jessica M ^a,c   Li, Patricia ^a   Lupu, Ruth ^a,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYER CORPORATION   (United States)

^c Microgenics Corporation   (United States)

^d Evanston NW Healthcare Res Inst ^*  (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Antiestrogen resistance; Breast cancer; Cyr61; Estrogen dependence; Invasiveness

Indexed keywords

ANGIOGENIC FACTOR; ANTIESTROGEN; CYSTEINE RICH PROTEIN 61; DNA; ESTROGEN; ESTROGEN RECEPTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER INVASION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INVASIVE CARCINOMA; METASTASIS; MOUSE; NONHUMAN; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADENOCARCINOMA; BREAST NEOPLASMS; COLLAGEN; DISEASE PROGRESSION; DOWN-REGULATION; DRUG COMBINATIONS; DRUG RESISTANCE, NEOPLASM; ENDOTHELIAL GROWTH FACTORS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMININ; LYMPHOKINES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROTEOGLYCANS; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS; MUS MUSCULUS;

EID: 0037153439     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205682     Document Type: Article

References (36)

1. Babic AM, Chen CC and Lau LF. (1999). Mol. Cell. Biol., 19, 2958-2966.
2. Babic AM, Kireeva ML, Kolesnikova TV and Lau LF. (1998). Proc. Natl. Acad. Sci. USA, 95, 6355-6360.
3. Brower ST, Cunningham JD and Tartter PI. (1999). Breast Cancer. Roses DF (ed). New York: Churchill Livingstone, pp 273-286.
4. Cardillo M, Tang C and Lupu R. (1995). Proc. AACR, 36, 262.
5. Cavailles V, Augereau P, Garcia M and Rochefort H. (1988). Nucleic Acids Res., 16, 1903-1919.
6. Chen N, Chen CC and Lau LF. (2000). J. Biol. Chem., 275, 24953-24961.
7. Chen CC, Mo FE and Lau LF. (2001). J. Biol. Chem., 276, 47329-47337.
8. Frazier K, Williams S, Kothapalli D, Klapper H and Grotendorst GR. (1996). J. Invest. Dermatol., 107, 404-411.
9. Gasparini G, Brooks PC, Biganzoli E, Vermeulen PB, Bonoldi E, Dirix LY, Ranieri G, Miceli R and Cheresh DA. (1998). Clin. Cancer Res., 4, 2625-2634.
10. Govind AP and Thampan RV. (2001). J. Cell. Biochem., 80, 571-579.
11. Guerra-Vladusic FK, Scott G, Weaver V, Vladusic EA, Tsai M-S, Benz CC and Lupu R. (1999). Int. J. Oncol., 15, 883-892.
12. Hijazi M, Thompson EW, Tang C, Coopman P, Torry JA, Yang D, Mueller SC and Lupu R. (2000). Int. J. Oncol., 17, 629-641.
13. Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF and Lam SC. (1999). J. Biol. Chem., 274, 24321-24327.
14. Kireeva ML, Lam SC and Lau LF. (1996a). J. Biol. Chem., 273, 3090-3096.
15. Kireeva ML, Mo F-E, Yang GP and Lau LF. (1996b). Mol. Cell. Biol., 16, 1326-1334.
16. Kireeva ML, Latinkic BV, Kolesnikova TV, Chen CC, Yang GP, Abler AS and Lau LF. (1997). Exp. Cell Res., 233, 63-77.
17. Kolesnikova TV and Lau LF. (1998). Oncogene, 16, 747-754.
18. Lau LF and Lam SC. (1999). Exp. Cell Res., 246, 44-57.
19. Lupu R, Cardillo M, Cho C, Harris L, Hijazi M, Perez C, Rosenberg K, Yang D and Tang C. (1996). Breast Cancer Res. Treat., 38, 57-66.
20. Lupu R, Cardillo M, Harris L, Hijazi M and Rosenberg K. (1995). Semin. Cancer Biol., 6, 135-145.
21. MacGregor JI and Jordan VC. (1998). Pharmacol. Rev., 50, 151-196.
22. Meyer T, Marshall JF and Hart IR. (1998). Br. J. Cancer, 77, 530-536.
23. Nardulli AM, Greene CL, O'Malley BW and Katzenellenbogen BS. (1988). Endocrinol., 122, 935-944.
24. O'Brien TP and Lau LF. (1992). Cell Growth Differ., 3, 645-654.
25. Pratt SE and Pollak MN. (1993). Cancer Res., 53, 5193-5198.
26. Read LS, Greene GL and Katzenellenbogen BS. (1989). Mol. Endocrinol., 3, 295-304.
27. Saceda M, Grunt TW, Colomer R, Lippman ME, Lupu R and Martin MB. (1996). Endocrinol., 137, 4322-4330.
28. Sampath D, Winneker RC and Zhang Z. (2001). Endocrinology, 142, 2540-2548.
29. Sommers CL, Thompson EW, Torri JA, Kemler R, Gelmann EP and Byers SW. (1991). Cell Growth Differ., 2, 365-372.
30. Tang C, Grunt TW, Cho C, Weibel C, Perez C and Lupu R. (1996). Cancer Res., 56, 3350-3358.
31. Tsai M-S, Hornby AE, Lakins J and Lupu R. (2000). Cancer Res., 60, 5603-5607.
32. Tsai M-S, Bogart DF, Li P, Mehmi I and Lupu R. (2002). Oncogene, 21, 964-973.
33. Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lakins J and Lupu R. (2000). Oncol. Rep., 7, 157-167.
34. Weaver CA, Springer PA and Katzenellenbogen BS. (1988). Mol. Endocrinol., 2, 936-945.
35. Xie D, Miller CW, O'Kelly J, Nakachi K, Sakashita A, Said JW, Gornbein J and Koeffler HP. (2001). J. Biol. Chem., 276, 14187-14194.
36. Yang PG and Lau FL. (1991). Cell Growth Differ., 2, 35l-357.